Additionally, as many of the protein targets discovered have strong associations to poorly understood disease mechanisms (e.g., APP in Alzheimer's disease and fat mass and obesity‐associated protein [FTO] in obesity), the installation and function of these modifications could play important roles in, or yield information about, the pathogenesis of these diseases. This evidence concerns the gene APP and obesity due to melanocortin 4 receptor deficiency.